06:01 PM EST, 02/04/2025 (MT Newswires) -- Kevin Charles Gorman, Director, on January 31, 2025, sold 2,707 shares in Neurocrine Biosciences ( NBIX ) for $413,967. Following the Form 4 filing with the SEC, Gorman has control over a total of 517,030 common shares of the company, with 517,030 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/914475/000091447525000031/xslF345X05/wk-form4_1738709906.xml